Pay with

USD

Supports Visa, MasterCard, SEPA & more

Flexible trading, zero fees

Use your crypto for payments worldwide

Basic

Trade crypto freely

Magnify your profit with leverage

Convert & Auto-Invest

Trade any size with no fees and no slippage

Get exposure to leveraged positions simply

Pre-Market Trading

Trade new tokens before listing

Advanced

Trade on-chain with Gate Wallet

Smart access to new on-chain tokens

Smart strategies with automated trading

Follow expert trading strategies

CrossEx Trading

One margin balance, shared across platforms

Access hundreds of perpetual contracts

One platform for global traditional assets

Trade European-style vanilla options

Unified Account

Maximize your capital efficiency

Introduction to Futures Trading

Learn the basics of futures trading

Join events to earn rewards

Use virtual funds to practice risk-free trading

Launch

Collect candies to earn airdrops

Quick staking, earn potential new tokens

Hold GT and get massive airdrops for free

Unlock full access to global stock IPOs

Trade on-chain assets and earn airdrops

Earn futures points and claim airdrop rewards

Investment

Earn interests with idle tokens

Auto-invest on a regular basis

Dual Investment

Profit from market volatility

Earn rewards with flexible staking

Pledge one crypto to borrow another

One-stop lending hub

Premium wealth growth plans

Private Wealth Management

Premium asset allocation

Top-tier quant strategies

Stake cryptos to earn in PoS products

No-liquidation leverage

Mint GUSD for RWA returns

Post, share, and explore crypto trends

Live crypto market analysis

Chat with crypto traders

What is happening in crypto

More

Core Scientific plans to issue $500 million convertible preferred notes

ChainCatcher

2024-12-03 01:13:53

CORE7,95%

ChainCatcher message, Core Scientific has completed a private sale issuance to qualified institutional buyers for a total of $5 billion of 2031 convertible senior notes. Core Scientific also intends to grant the initial purchasers of the notes the option to engage in Settlement within 13 days (inclusive) from the date of the first issuance, with the option to purchase an additional $75 million in principal amount of the notes. Core Scientific intends to use the net proceeds from this issuance for general corporate purposes, including working capital, operating expenses, capital expenditures, acquisition of complementary businesses, or repurchase of its securities.

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.

Comment

0/400

No comments